The DOI matches its Crossref record; 418 of the 418 references it cites were found in a registry or an index.
The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine Systems
Open accessAbstract
Opioid abuse has increased in the last decade, primarily as a result of increased access to prescription opioids. Physicians are also increasingly administering opioid analgesics for noncancer chronic pain. Thus, knowledge of the long-term consequences of opioid use/abuse has important implications for fully evaluating the clinical usefulness of opioid medications. Many studies have examined the effect of opioids on the endocrine system; however, a systematic review of the endocrine actions of opioids in both humans and animals has, to our knowledge, not been published since 1984. Thus, we reviewed the literature on the effect of opioids on the endocrine system. We included both acute and chronic effects of opioids, with the majority of the studies done on the acute effects although chronic effects are more physiologically relevant. In humans and laboratory animals, opioids generally increase GH and prolactin and decrease LH, testosterone, estradiol, and oxytocin. In humans, opioids increase TSH, whereas in rodents, TSH is decreased. In both rodents and humans, the reports of effects of opioids on arginine vasopressin and ACTH are conflicting. Opioids act preferentially at different receptor sites leading to stimulatory or inhibitory effects on hormone release. Increasing opioid abuse primarily leads to hypogonadism but may also affect the secretion of other pituitary hormones. The potential consequences of hypogonadism include decreased libido and erectile dysfunction in men, oligomenorrhea or amenorrhea in women, and bone loss or infertility in both sexes. Opioids may increase or decrease food intake, depending on the type of opioid and the duration of action. Additionally, opioids may act through the sympathetic nervous system to cause hyperglycemia and impaired insulin secretion. In this review, recent information regarding endocrine disorders among opioid abusers is presented.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, it is important to keep in mind that some medications (eg, high doses of heparins, phenobarbital, opioids, and etomidate) used in the ICU may adversely impact endocrine function or may alter the accuracy of laboratory testing (152, 153).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [153]
In the citing paper
“Opioids inhibit pulsatile GnRH secretion from the hypothalamus and the secretion of gonadotropins (mainly LH and to a lesser extent FSH) from the pituitary gland and of sex steroids from the gonads (61)(62)(63)(64).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [63]
In the citing paper
“In animals, depending on the dose, timing and duration, opioids have been shown to variably stimulate or inhibit the CRH/ACTH axis, whereas in humans they predominantly inhibit it [61].”
In the citing paper
“The physiological relationship between the opioid and OT systems has been firmly established (20).”
From Oxytocin under opioid antagonism leads to supralinear enhancement of social attention (2017) · cites this paper as [20]
Citations
Cites
Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2009) · PsycEXTRA Dataset · doi:10.1037/e560352009-001 · Cited by 6,921
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722
How does stress increase risk of drug abuse and relapse?
Sinha, R. (2001) · Psychopharmacology · doi:10.1007/s002130100917 · Cited by 1,505
A potent and selective endogenous agonist for the µ-opiate receptor
Zadina, J. E., Hackler, L., Ge, L.-J., & Kastin, A. J. (1997) · Nature · doi:10.1038/386499a0 · Cited by 1,311
Endogenous Opioids: Biology and Function
Akil, H., Watson, S. J., Young, E., Lewis, M. E., Khachaturian, H., & Walker, J. M. (1984) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.07.030184.001255 · Cited by 1,224
Common precursor to corticotropins and endorphins
Mains, R. E., Eipper, B. A., & Ling, N. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.7.3014 · Cited by 1,105 · cited 1×
“Subsequently, CRH binds to its receptor in the anterior pituitary that leads to the synthesis of POMC, a large precursor molecule that is cleaved into several smaller functional peptides, such as ACTH and -endorphin (67).”
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079 · cited 1×
“been established unequivocally (288), some studies indi-”
Opioid Therapy for Chronic Pain
Ballantyne, J. C., & Mao, J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra025411 · Cited by 959 · cited 2×
“-Endorphin Leu-enkephalin 0 Met-enkephalin 0 Dynorphin A (1-17) 0 Endomorphin-1 0 0 Endomorphin-2 0 0 Morphine 0 Heroin 0 Fentanyl 0 0 Sufentanil 0 0 Methadone 0 0 DALA (FK 33-824) 0 DAMME 0 U50,488H 0 0 Nalorphine 0 Naloxone Naltrexone CTOP 0 0 Buprenorphine / (?) Pentazocin 0”
Major increases in opioid analgesic abuse in the United States: Concerns and strategies
Compton, W. M., & Volkow, N. D. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.05.009 · Cited by 830 · cited 3×
“-Endorphin Leu-enkephalin 0 Met-enkephalin 0 Dynorphin A (1-17) 0 Endomorphin-1 0 0 Endomorphin-2 0 0 Morphine 0 Heroin 0 Fentanyl 0 0 Sufentanil 0 0 Methadone 0 0 DALA (FK 33-824) 0 DAMME 0 U50,488H 0 0 Nalorphine 0 Naloxone Naltrexone CTOP 0 0 Buprenorphine / (?) Pentazocin 0”
Research works printed but not linked: 2
- 2009, International Narcotics Control Board 2007, March, press release no. 4: Abuse of prescription drugs to surpass illicit drug abuse, Drug Watch International, 12, 14
- Mansour, 1987, Autoradiographic differentiation of μ, δ, and κ opioid receptors in the rat forebrain and midbrain., J Neurosci, 7, 2445
Cited by
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031914-122957 · Cited by 1,388
Clinical Management of Congenital Hypogonadotropic Hypogonadism
Young, J., Xu, C., Papadakis, G. E., Acierno, J. S., Maione, L., Hietamäki, J., Raivio, T., & Pitteloud, N. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00116 · Cited by 396
Mechanisms of Penile Erection and Basis for Pharmacological Treatment of Erectile Dysfunction
Andersson, K.-E. (2011) · Pharmacological Reviews · doi:10.1124/pr.111.004515 · Cited by 392
“…injection of opioids can lead to decreased libido and ED (Parr, 1976; Crowley and Simpson, 1978; Mirin et al., 1980; Abs et al., 2000; Hallinan et al., 2008), possibly because of hypogonadotropic hypogonadism (Mirin et al., 1980; Abs et al., 2000; Hallinan et al., 2008; Vuong et al., 2010).”
BackgroundJanssen, P., Vanden Berghe, P., Verschueren, S., Lehmann, A., Depoortere, I., & Tack, J. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04609.x · Cited by 348
“whether normal weight, low weight (anorexia patients) or obese volunteers ⁄ patients are selected.(132) We recently”
BackgroundBasaria, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61126-5 · Cited by 328
Metadata
- Authors
- Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C.
- Affiliations
- Charles R. Drew University of Medicine and Science (US)
- Department of Medicine (S.H.M.V.U.), University of Western Ontario, London, Ontario, Canada N6A 4V2;
- Department of Psychology (L.E.O.), University of Texas at El Paso, El Paso, Texas 79968;
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2009-11-10
- Volume
- 31
- Issue
- 1
- Pages
- 98-132
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC2852206
- OpenAlex
- W2121855288
- Semantic Scholar
- b1cd06bbab24029ae38ff691e325cd99457b8455
- Cited by
- 564
- References
- 418
- Citations by year
- 2026: 22 · 2025: 33 · 2024: 25 · 2023: 34 · 2022: 36 · 2021: 37 · 2020: 35 · 2019: 41 · 2018: 52 · 2017: 32 · 2016: 37 · 2015: 42 · 2014: 34 · 2013: 29 · 2012: 32
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5u54rr014616-10)
- National Institute on Drug Abuse (R01DA014659, R01 DA14659, R01 DA16682, R01DA016682, R01DA021274, R24DA017298, R25DA033613)
- National Center for Research Resources (U54-RR14616, G12RR003026, U54-RR0 14616, G21 RR03026)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD41748, U54HD041748)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- opioids, opioid analgesics, endocrine effects, growth hormone, prolactin, luteinizing hormone, testosterone, estradiol, oxytocin, thyroid-stimulating hormone, vasopressin, ACTH, opioid receptors, hypogonadism, dietary intake, hyperglycemia, insulin secretion, chronic pain, opioid abuse
- MeSH terms
- Analgesics, Opioid, Animals, Endocrine System Diseases, Endocrine System, Female, Humans, Hypogonadism, Male, Opioid-Related Disorders, Opiate Alkaloids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine Systems. https://app.cochat.ai/papers/10.1210/er.2009-0009
- The paper
- Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010). The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine Systems. Endocrine Reviews. https://doi.org/10.1210/er.2009-0009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.